In a systematic review and meta-analysis of the prevalence of oncogenic driver mutations in Hispanic/Latino patients with lung cancer around the world, the overall frequency of the ALK rearrangement was estimated to be 5% (95% CI, 4%–6%; ref. 33). This evidence concerns the gene ALK and lung cancer.